Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 2)

v3.24.3
Stockholders' Equity (Details 2) - Restricted Stock Units (RSUs) [Member] - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options outstanding at beginning of period 67,250  
Weighted average exercise price at beginning of period $ 2.25  
Weighted average remaining life (years) 1 year 10 months 17 days 2 years 25 days
Aggregate intrinsic value at beginning of period $ 40,350  
Number of options, Granted 87,300  
Weighted average grant - date fair value price, Granted $ 0.84  
Aggregate intrinsic value Granted $ 52,380  
Number of options, Exercised 0  
Weighted average exercise price, Exercised $ 0  
Aggregate intrinsic value Exercised $ 0  
Number of options, Forfeited/canceled (55,124)  
Weighted average exercise price, Forfeited/canceled $ (1.31)  
Aggregate intrinsic value Forfeited/canceled $ (33,074)  
Number of options outstanding at ending of period 99,426 67,250
Weighted average exercise price at ending of period $ 1.53 $ 2.25
Aggregate intrinsic value at ending of period $ 59,655 $ 40,350